Fisher & Paykel Healthcare Corporation Limited

OVERVALUEDFSPKF · OTC · Healthcare
FSPKF·OTC·Healthcare
OVERVALUED
Fisher & Paykel Healthcare Corporation Limited
42.4%downside
MARKET PRICE
$23.02
FAIR PRICE
$13.26
MARGIN
$9.76
UNDERVALUEDFAIROVERVALUED
P/E RATIO
35.1x
DIV. YIELD
1.53%
ROE
36.2%
MARKET CAP
$23B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

42.4%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$23.02

FAIR PRICE

$13.26

MARGIN

$9.76

UNDERVALUEDFAIROVERVALUED

P/E Ratio

35.1x

What is P/E? →

Div. Yield

1.53%

ROE

36.2%

Exceptional

Market Cap

$23B

Large-cap

NOW AVAILABLE

Get notified when FSPKF's fair price changes

Push notifications when FSPKF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

5.8/ 10

Low debt levels, but limited growth momentum and expensive valuation relative to fundamentals.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$10.61CONSERVATIVE ENTRY
$13.26FAIR PRICE
$23.02MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$10.61

Fair price × 0.80

DISTANCE

53.9%

Price to entry level

At the current price of $23.02, FSPKF trades 53.9% above the conservative entry level of $10.61. This entry level represents a 20% margin of safety below the calculated fair price of $13.26 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate FSPKF's fair price

Fisher & Paykel Healthcare Corporation Limited's fair price of $13.26 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $23.02, FSPKF trades 42.4% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting FSPKF's risk profile.

RELATIVE · 30%

Comparing FSPKF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for FSPKF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate FSPKF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for FSPKF.

Explore on Bulios

FAQ

What is the fair price of FSPKF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Fisher & Paykel Healthcare Corporation Limited is $13.26. At the current market price of $23.02, FSPKF trades 42.4% above its calculated fair value.

Is FSPKF overvalued or undervalued?+

Fisher & Paykel Healthcare Corporation Limited is currently overvalued based on our valuation model. The stock trades at $23.02, which is 42.4% above the fair price of $13.26. The P/E ratio of 35.1x is a key metric in the valuation.

What is the margin of safety for FSPKF?+

With a 20% margin of safety applied to the fair price of $13.26, the conservative entry level for FSPKF is $10.61. At the current market price of $23.02, the stock trades 53.9% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is FSPKF's fair price updated?+

We update fair price calculations for FSPKF daily after market close. The current fair price of $13.26 incorporates the latest market data and sector multiples.

What factors affect FSPKF's fair price calculation?+

FSPKF's fair price of $13.26 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 35.1x, ROE of 36.2%, and dividend yield of 1.53%.

Is FSPKF a good buy right now?+

At $23.02, FSPKF trades 42.4% above our fair value estimate of $13.26. The stock is currently overvalued. ROE stands at 36.2% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.

Does FSPKF pay dividends?+

FSPKF has a dividend yield of 1.53%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.